

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.13723158 |
| 2 | * negative regulation of cell killing (GO:0031342) | 7.00944074 |
| 3 | * negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.00944074 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.26853988 |
| 5 | negative T cell selection (GO:0043383) | 6.07152809 |
| 6 | negative thymic T cell selection (GO:0045060) | 5.91698163 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.73613195 |
| 8 | positive thymic T cell selection (GO:0045059) | 5.49017444 |
| 9 | regulation of gamma-delta T cell activation (GO:0046643) | 5.35573561 |
| 10 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.34020441 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.14960103 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.02368470 |
| 13 | interferon-gamma production (GO:0032609) | 4.95951725 |
| 14 | positive T cell selection (GO:0043368) | 4.89497666 |
| 15 | tolerance induction (GO:0002507) | 4.83035130 |
| 16 | T cell migration (GO:0072678) | 4.82353691 |
| 17 | thymic T cell selection (GO:0045061) | 4.75404799 |
| 18 | T cell selection (GO:0045058) | 4.63431312 |
| 19 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.57052594 |
| 20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.57052594 |
| 21 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.56003370 |
| 22 | leukocyte aggregation (GO:0070486) | 4.32610441 |
| 23 | positive regulation of isotype switching (GO:0045830) | 4.22655199 |
| 24 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.13046430 |
| 25 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 4.11323554 |
| 26 | T-helper cell differentiation (GO:0042093) | 4.11323554 |
| 27 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.10096471 |
| 28 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.09864281 |
| 29 | regulation of regulatory T cell differentiation (GO:0045589) | 4.05439979 |
| 30 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.03486469 |
| 31 | positive regulation of B cell mediated immunity (GO:0002714) | 3.96904860 |
| 32 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.96904860 |
| 33 | B cell receptor signaling pathway (GO:0050853) | 3.95569507 |
| 34 | neutrophil activation involved in immune response (GO:0002283) | 3.95221039 |
| 35 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.90543056 |
| 36 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.90543056 |
| 37 | T cell receptor signaling pathway (GO:0050852) | 3.87673693 |
| 38 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.87217369 |
| 39 | T cell costimulation (GO:0031295) | 3.84353356 |
| 40 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.82890124 |
| 41 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.82890124 |
| 42 | lymphocyte costimulation (GO:0031294) | 3.80949520 |
| 43 | negative regulation of interleukin-12 production (GO:0032695) | 3.80343182 |
| 44 | activated T cell proliferation (GO:0050798) | 3.79632698 |
| 45 | * response to interleukin-15 (GO:0070672) | 3.79392283 |
| 46 | positive regulation of DNA recombination (GO:0045911) | 3.79216425 |
| 47 | regulation of response to interferon-gamma (GO:0060330) | 3.78740418 |
| 48 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.74091691 |
| 49 | * cellular response to interleukin-15 (GO:0071350) | 3.70794179 |
| 50 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.69801955 |
| 51 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.69801955 |
| 52 | T cell differentiation involved in immune response (GO:0002292) | 3.69801955 |
| 53 | NIK/NF-kappaB signaling (GO:0038061) | 3.69375890 |
| 54 | * negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.69086288 |
| 55 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.67220723 |
| 56 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.66245611 |
| 57 | positive regulation of humoral immune response (GO:0002922) | 3.62687479 |
| 58 | regulation of B cell differentiation (GO:0045577) | 3.60491175 |
| 59 | regulation of chronic inflammatory response (GO:0002676) | 3.59133123 |
| 60 | neutrophil activation (GO:0042119) | 3.56644592 |
| 61 | regulation of isotype switching (GO:0045191) | 3.56368036 |
| 62 | * negative regulation of T cell mediated immunity (GO:0002710) | 3.56300843 |
| 63 | positive regulation of interleukin-17 production (GO:0032740) | 3.55209991 |
| 64 | * regulation of T cell mediated cytotoxicity (GO:0001914) | 3.54714225 |
| 65 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.54063799 |
| 66 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.53099181 |
| 67 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.52963749 |
| 68 | granulocyte activation (GO:0036230) | 3.48686654 |
| 69 | regulation of B cell mediated immunity (GO:0002712) | 3.47160603 |
| 70 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.46320089 |
| 71 | regulation of T cell tolerance induction (GO:0002664) | 3.46248960 |
| 72 | positive regulation of interleukin-2 production (GO:0032743) | 3.44853202 |
| 73 | positive regulation of granulocyte differentiation (GO:0030854) | 3.43450436 |
| 74 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.43319136 |
| 75 | leukocyte cell-cell adhesion (GO:0007159) | 3.41373462 |
| 76 | positive regulation of tolerance induction (GO:0002645) | 3.40875028 |
| 77 | regulation of immune response to tumor cell (GO:0002837) | 3.40263071 |
| 78 | regulation of response to tumor cell (GO:0002834) | 3.40263071 |
| 79 | positive regulation of response to tumor cell (GO:0002836) | 3.40263071 |
| 80 | positive regulation of immune response to tumor cell (GO:0002839) | 3.40263071 |
| 81 | natural killer cell activation (GO:0030101) | 3.39324930 |
| 82 | cellular response to type I interferon (GO:0071357) | 3.37942917 |
| 83 | regulation of tolerance induction (GO:0002643) | 3.37394310 |
| 84 | * regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.37259699 |
| 85 | positive regulation of mast cell activation (GO:0033005) | 3.35750067 |
| 86 | regulation of activation of Janus kinase activity (GO:0010533) | 3.33445371 |
| 87 | alpha-beta T cell activation (GO:0046631) | 3.33431498 |
| 88 | lymphocyte migration (GO:0072676) | 3.33058448 |
| 89 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.32366759 |
| 90 | mast cell activation (GO:0045576) | 3.28825417 |
| 91 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.27815536 |
| 92 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.25805212 |
| 93 | positive regulation of cell killing (GO:0031343) | 3.25569666 |
| 94 | myeloid dendritic cell activation (GO:0001773) | 3.23848732 |
| 95 | alpha-beta T cell differentiation (GO:0046632) | 3.22047837 |
| 96 | T cell activation involved in immune response (GO:0002286) | 3.21305692 |
| 97 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.19769879 |
| 98 | * negative regulation of leukocyte mediated immunity (GO:0002704) | 3.19478549 |
| 99 | cellular extravasation (GO:0045123) | 3.15159699 |
| 100 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.14191789 |
| 101 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.14191789 |
| 102 | * regulation of cell killing (GO:0031341) | 3.14028728 |
| 103 | * B cell proliferation (GO:0042100) | 3.12886866 |
| 104 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.10766079 |
| 105 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.10123027 |
| 106 | myeloid dendritic cell differentiation (GO:0043011) | 3.07248570 |
| 107 | heterotypic cell-cell adhesion (GO:0034113) | 3.06463467 |
| 108 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.05721575 |
| 109 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.05721575 |
| 110 | modulation by symbiont of host immune response (GO:0052553) | 3.05721575 |
| 111 | positive regulation by symbiont of host defense response (GO:0052509) | 3.05721575 |
| 112 | modulation by symbiont of host defense response (GO:0052031) | 3.05721575 |
| 113 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.05721575 |
| 114 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.05417045 |
| 115 | response to muramyl dipeptide (GO:0032495) | 3.05072530 |
| 116 | regulation of alpha-beta T cell activation (GO:0046634) | 3.04391308 |
| 117 | response to type I interferon (GO:0034340) | 3.03975442 |
| 118 | macrophage activation involved in immune response (GO:0002281) | 3.03940244 |
| 119 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.03881519 |
| 120 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.02591689 |
| 121 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.02472413 |
| 122 | type I interferon signaling pathway (GO:0060337) | 3.01595641 |
| 123 | negative regulation of innate immune response (GO:0045824) | 3.00523133 |
| 124 | defense response to protozoan (GO:0042832) | 2.94977483 |
| 125 | detection of other organism (GO:0098543) | 2.93639873 |
| 126 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.93282437 |
| 127 | positive regulation of T cell mediated immunity (GO:0002711) | 2.92959695 |
| 128 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.92487040 |
| 129 | dendritic cell chemotaxis (GO:0002407) | 2.92304904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.13884489 |
| 2 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.96052166 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.69330189 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.67499532 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.43015257 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.18149282 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.96507374 |
| 8 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.92299760 |
| 9 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 3.50404425 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.47255502 |
| 11 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.44913312 |
| 12 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.39278969 |
| 13 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.26803891 |
| 14 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.22526016 |
| 15 | * MYB_26560356_Chip-Seq_TH2_Human | 3.06875295 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.98023123 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.94468627 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.72351165 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.55947892 |
| 20 | * MAF_26560356_Chip-Seq_TH1_Human | 2.50222299 |
| 21 | MYB_26560356_Chip-Seq_TH1_Human | 2.48203681 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.47122734 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.31711168 |
| 24 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.28408754 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 2.26671870 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11042783 |
| 27 | UTX_26944678_Chip-Seq_JUKART_Human | 2.09145743 |
| 28 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.04458771 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.02967549 |
| 30 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.94040567 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.91228524 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.90186019 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.89117086 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.85451002 |
| 35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.82725911 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.82269849 |
| 37 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.80867966 |
| 38 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.70989098 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.70545716 |
| 40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.66597733 |
| 41 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.64603900 |
| 42 | MAF_26560356_Chip-Seq_TH2_Human | 1.62637372 |
| 43 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.62059261 |
| 44 | SPI1_23127762_ChIP-Seq_K562_Human | 1.55795538 |
| 45 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.54775172 |
| 46 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.53691055 |
| 47 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.44439249 |
| 48 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.43944805 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42436995 |
| 50 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.42179795 |
| 51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.42128636 |
| 52 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.39701063 |
| 53 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.37629438 |
| 54 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37290409 |
| 55 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36665660 |
| 56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.36384722 |
| 57 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35970295 |
| 58 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.30191958 |
| 59 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28352139 |
| 60 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.25837241 |
| 61 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21819075 |
| 62 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.17023941 |
| 63 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15677822 |
| 64 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14421816 |
| 65 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14111117 |
| 66 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.13961483 |
| 67 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11948440 |
| 68 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.05097629 |
| 69 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.02504470 |
| 70 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00913091 |
| 71 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00048131 |
| 72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98598823 |
| 73 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97961947 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96406578 |
| 75 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96243062 |
| 76 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95072399 |
| 77 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93656086 |
| 78 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93130773 |
| 79 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91675400 |
| 80 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90493941 |
| 81 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90445147 |
| 82 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89846129 |
| 83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.79789582 |
| 84 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.77144763 |
| 85 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.76669260 |
| 86 | GATA3_26560356_Chip-Seq_TH1_Human | 0.75758044 |
| 87 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.74699016 |
| 88 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.73916549 |
| 89 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.73865016 |
| 90 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.73291192 |
| 91 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.71821047 |
| 92 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.70009581 |
| 93 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.69385876 |
| 94 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.68798740 |
| 95 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.68308130 |
| 96 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.67965374 |
| 97 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67613115 |
| 98 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.67499078 |
| 99 | GATA2_19941826_ChIP-Seq_K562_Human | 0.67256000 |
| 100 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.67007562 |
| 101 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.66881362 |
| 102 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.65770109 |
| 103 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64551223 |
| 104 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.64254363 |
| 105 | GATA1_19941826_ChIP-Seq_K562_Human | 0.63000886 |
| 106 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.62742451 |
| 107 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.60272894 |
| 108 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.58206020 |
| 109 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.57800485 |
| 110 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.57268372 |
| 111 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.57037028 |
| 112 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.52445785 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.19839276 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.88951826 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.83853773 |
| 4 | MP0009785_altered_susceptibility_to | 3.66445606 |
| 5 | MP0000685_abnormal_immune_system | 3.49079304 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.36833157 |
| 7 | MP0006082_CNS_inflammation | 3.26062646 |
| 8 | MP0005387_immune_system_phenotype | 3.24967559 |
| 9 | MP0001790_abnormal_immune_system | 3.24967559 |
| 10 | MP0001800_abnormal_humoral_immune | 3.18415669 |
| 11 | MP0003436_decreased_susceptibility_to | 3.04101134 |
| 12 | MP0002723_abnormal_immune_serum | 2.94529717 |
| 13 | MP0003303_peritoneal_inflammation | 2.94072726 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.86661122 |
| 15 | MP0005025_abnormal_response_to | 2.80662004 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.79500531 |
| 17 | * MP0001819_abnormal_immune_cell | 2.75040420 |
| 18 | * MP0002420_abnormal_adaptive_immunity | 2.74650602 |
| 19 | MP0002405_respiratory_system_inflammati | 2.64263732 |
| 20 | MP0002419_abnormal_innate_immunity | 2.60936772 |
| 21 | MP0003724_increased_susceptibility_to | 2.58871121 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.37809608 |
| 23 | * MP0002398_abnormal_bone_marrow | 2.37501992 |
| 24 | MP0002166_altered_tumor_susceptibility | 2.35998523 |
| 25 | MP0004510_myositis | 2.29655528 |
| 26 | * MP0000716_abnormal_immune_system | 2.23676551 |
| 27 | MP0004947_skin_inflammation | 2.20016584 |
| 28 | MP0010155_abnormal_intestine_physiology | 2.17752934 |
| 29 | MP0002006_tumorigenesis | 2.07867693 |
| 30 | MP0003300_gastrointestinal_ulcer | 2.07464558 |
| 31 | MP0001853_heart_inflammation | 1.98812102 |
| 32 | * MP0002722_abnormal_immune_system | 1.93552857 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.93280543 |
| 34 | * MP0000689_abnormal_spleen_morphology | 1.91344310 |
| 35 | MP0000858_altered_metastatic_potential | 1.88558703 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.88489830 |
| 37 | * MP0000703_abnormal_thymus_morphology | 1.82914654 |
| 38 | MP0001873_stomach_inflammation | 1.79671160 |
| 39 | * MP0002429_abnormal_blood_cell | 1.78338213 |
| 40 | MP0002933_joint_inflammation | 1.74390332 |
| 41 | MP0003448_altered_tumor_morphology | 1.71170298 |
| 42 | MP0005310_abnormal_salivary_gland | 1.67875231 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.57685470 |
| 44 | MP0003866_abnormal_defecation | 1.57564871 |
| 45 | MP0002138_abnormal_hepatobiliary_system | 1.52993636 |
| 46 | MP0002998_abnormal_bone_remodeling | 1.43866877 |
| 47 | MP0008469_abnormal_protein_level | 1.35381886 |
| 48 | MP0004381_abnormal_hair_follicle | 1.33290131 |
| 49 | MP0002396_abnormal_hematopoietic_system | 1.33161938 |
| 50 | MP0001851_eye_inflammation | 1.28793668 |
| 51 | MP0005058_abnormal_lysosome_morphology | 1.26928100 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.21634886 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.21634886 |
| 54 | MP0009764_decreased_sensitivity_to | 1.21216143 |
| 55 | MP0003172_abnormal_lysosome_physiology | 1.08318921 |
| 56 | MP0009278_abnormal_bone_marrow | 1.07154761 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 1.05504207 |
| 58 | MP0004808_abnormal_hematopoietic_stem | 1.04480740 |
| 59 | MP0004883_abnormal_blood_vessel | 1.02697561 |
| 60 | MP0008260_abnormal_autophagy | 0.99932817 |
| 61 | MP0005451_abnormal_body_composition | 0.98694287 |
| 62 | MP0000490_abnormal_crypts_of | 0.96822935 |
| 63 | MP0005075_abnormal_melanosome_morpholog | 0.95282948 |
| 64 | MP0005166_decreased_susceptibility_to | 0.94587713 |
| 65 | MP0003045_fibrosis | 0.90493354 |
| 66 | MP0002009_preneoplasia | 0.90281929 |
| 67 | MP0002019_abnormal_tumor_incidence | 0.88549246 |
| 68 | MP0002277_abnormal_respiratory_mucosa | 0.87042098 |
| 69 | MP0000343_altered_response_to | 0.86620742 |
| 70 | MP0005076_abnormal_cell_differentiation | 0.86062052 |
| 71 | MP0009763_increased_sensitivity_to | 0.86016585 |
| 72 | MP0005164_abnormal_response_to | 0.85788100 |
| 73 | MP0003690_abnormal_glial_cell | 0.82592801 |
| 74 | MP0000569_abnormal_digit_pigmentation | 0.81646769 |
| 75 | MP0009840_abnormal_foam_cell | 0.81594646 |
| 76 | MP0004130_abnormal_muscle_cell | 0.78889374 |
| 77 | MP0003453_abnormal_keratinocyte_physiol | 0.76973007 |
| 78 | MP0002254_reproductive_system_inflammat | 0.74956782 |
| 79 | MP0005167_abnormal_blood-brain_barrier | 0.73249672 |
| 80 | MP0006054_spinal_hemorrhage | 0.73058340 |
| 81 | MP0003075_altered_response_to | 0.72151164 |
| 82 | MP0003828_pulmonary_edema | 0.71935858 |
| 83 | MP0000249_abnormal_blood_vessel | 0.70859627 |
| 84 | MP0001348_abnormal_lacrimal_gland | 0.69691408 |
| 85 | MP0010352_gastrointestinal_tract_polyps | 0.69034122 |
| 86 | MP0002332_abnormal_exercise_endurance | 0.68831270 |
| 87 | MP0002136_abnormal_kidney_physiology | 0.66796142 |
| 88 | MP0001881_abnormal_mammary_gland | 0.65434442 |
| 89 | MP0003795_abnormal_bone_structure | 0.64676075 |
| 90 | MP0002132_abnormal_respiratory_system | 0.63155791 |
| 91 | MP0000371_diluted_coat_color | 0.62673720 |
| 92 | MP0008004_abnormal_stomach_pH | 0.61360019 |
| 93 | MP0008057_abnormal_DNA_replication | 0.61343621 |
| 94 | MP0000604_amyloidosis | 0.61335948 |
| 95 | MP0005390_skeleton_phenotype | 0.60916182 |
| 96 | MP0005174_abnormal_tail_pigmentation | 0.60643552 |
| 97 | MP0001986_abnormal_taste_sensitivity | 0.60446809 |
| 98 | MP0001501_abnormal_sleep_pattern | 0.58640451 |
| 99 | MP0001663_abnormal_digestive_system | 0.58044980 |
| 100 | MP0000015_abnormal_ear_pigmentation | 0.57718643 |
| 101 | MP0003091_abnormal_cell_migration | 0.57412563 |
| 102 | MP0005023_abnormal_wound_healing | 0.54582907 |
| 103 | MP0010307_abnormal_tumor_latency | 0.53712155 |
| 104 | MP0009765_abnormal_xenobiotic_induced | 0.53307431 |
| 105 | MP0001919_abnormal_reproductive_system | 0.52703308 |
| 106 | MP0000609_abnormal_liver_physiology | 0.52409390 |
| 107 | MP0001243_abnormal_dermal_layer | 0.50984949 |
| 108 | MP0003183_abnormal_peptide_metabolism | 0.50127253 |
| 109 | MP0003656_abnormal_erythrocyte_physiolo | 0.49643361 |
| 110 | MP0002693_abnormal_pancreas_physiology | 0.48850259 |
| 111 | MP0008874_decreased_physiological_sensi | 0.48449983 |
| 112 | MP0000920_abnormal_myelination | 0.48193823 |
| 113 | MP0003191_abnormal_cellular_cholesterol | 0.45700724 |
| 114 | MP0000627_abnormal_mammary_gland | 0.45553012 |
| 115 | MP0001191_abnormal_skin_condition | 0.44277099 |
| 116 | MP0003566_abnormal_cell_adhesion | 0.43226557 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * T lymphocytopenia (HP:0005403) | 5.62873112 |
| 2 | Retrobulbar optic neuritis (HP:0100654) | 5.59156802 |
| 3 | Optic neuritis (HP:0100653) | 5.59156802 |
| 4 | * Abnormality of T cell number (HP:0011839) | 5.54489634 |
| 5 | Myositis (HP:0100614) | 5.43383376 |
| 6 | Orchitis (HP:0100796) | 5.19981341 |
| 7 | Eczematoid dermatitis (HP:0000976) | 5.18838288 |
| 8 | Recurrent abscess formation (HP:0002722) | 5.03215604 |
| 9 | Stomatitis (HP:0010280) | 4.72463668 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.59853492 |
| 11 | Recurrent fungal infections (HP:0002841) | 4.56050147 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 4.38734119 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 4.20594648 |
| 14 | Pulmonary infiltrates (HP:0002113) | 3.95270956 |
| 15 | Recurrent bronchitis (HP:0002837) | 3.93716192 |
| 16 | Recurrent viral infections (HP:0004429) | 3.92892780 |
| 17 | Autoimmune thrombocytopenia (HP:0001973) | 3.91881382 |
| 18 | Vasculitis (HP:0002633) | 3.91723138 |
| 19 | Keratoconjunctivitis sicca (HP:0001097) | 3.87482172 |
| 20 | Obstructive lung disease (HP:0006536) | 3.87407422 |
| 21 | Chronic obstructive pulmonary disease (HP:0006510) | 3.87407422 |
| 22 | * Abnormality of T cells (HP:0002843) | 3.85068495 |
| 23 | Hemoptysis (HP:0002105) | 3.79058323 |
| 24 | Meningitis (HP:0001287) | 3.64081853 |
| 25 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.60557807 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 3.57959390 |
| 27 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.57959390 |
| 28 | Gastrointestinal infarctions (HP:0005244) | 3.52238813 |
| 29 | Keratoconjunctivitis (HP:0001096) | 3.51260243 |
| 30 | IgG deficiency (HP:0004315) | 3.45929933 |
| 31 | Arterial thrombosis (HP:0004420) | 3.44122585 |
| 32 | * Combined immunodeficiency (HP:0005387) | 3.38237582 |
| 33 | Abnormality of the prostate (HP:0008775) | 3.38229324 |
| 34 | Recurrent skin infections (HP:0001581) | 3.36773376 |
| 35 | IgM deficiency (HP:0002850) | 3.36095313 |
| 36 | Abnormality of macrophages (HP:0004311) | 3.33579305 |
| 37 | * Severe combined immunodeficiency (HP:0004430) | 3.27081029 |
| 38 | Nasal polyposis (HP:0100582) | 3.21662822 |
| 39 | Pustule (HP:0200039) | 3.12563440 |
| 40 | Chronic otitis media (HP:0000389) | 3.09945748 |
| 41 | Gingivitis (HP:0000230) | 3.04399340 |
| 42 | Agammaglobulinemia (HP:0004432) | 2.93851974 |
| 43 | Increased IgM level (HP:0003496) | 2.91830944 |
| 44 | Gangrene (HP:0100758) | 2.91566594 |
| 45 | * Leukocytosis (HP:0001974) | 2.91495295 |
| 46 | Vacuolated lymphocytes (HP:0001922) | 2.90989668 |
| 47 | Joint swelling (HP:0001386) | 2.86819856 |
| 48 | Pulmonary embolism (HP:0002204) | 2.86619536 |
| 49 | Lymphopenia (HP:0001888) | 2.86339722 |
| 50 | Abnormality of B cell number (HP:0010975) | 2.84299397 |
| 51 | B lymphocytopenia (HP:0010976) | 2.84299397 |
| 52 | Chronic diarrhea (HP:0002028) | 2.82773993 |
| 53 | Eosinophilia (HP:0001880) | 2.80135893 |
| 54 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.78817712 |
| 55 | * Thyroiditis (HP:0100646) | 2.73730541 |
| 56 | Encephalitis (HP:0002383) | 2.70637559 |
| 57 | Cellulitis (HP:0100658) | 2.68500045 |
| 58 | * Abnormality of eosinophils (HP:0001879) | 2.68203958 |
| 59 | Abnormality of the nasal mucosa (HP:0000433) | 2.65919552 |
| 60 | Autoimmune hemolytic anemia (HP:0001890) | 2.64944930 |
| 61 | Increased IgE level (HP:0003212) | 2.59112893 |
| 62 | Panhypogammaglobulinemia (HP:0003139) | 2.58771611 |
| 63 | Anorexia (HP:0002039) | 2.57395791 |
| 64 | Hematochezia (HP:0002573) | 2.52396143 |
| 65 | Chest pain (HP:0100749) | 2.50385197 |
| 66 | Verrucae (HP:0200043) | 2.48181227 |
| 67 | Papilloma (HP:0012740) | 2.48181227 |
| 68 | Stomach cancer (HP:0012126) | 2.47945553 |
| 69 | Periodontitis (HP:0000704) | 2.46877185 |
| 70 | Epistaxis (HP:0000421) | 2.46561761 |
| 71 | Abnormality of T cell physiology (HP:0011840) | 2.45919328 |
| 72 | Spontaneous hematomas (HP:0007420) | 2.44610416 |
| 73 | Hypoplasia of the thymus (HP:0000778) | 2.43559740 |
| 74 | Abnormality of the fingertips (HP:0001211) | 2.42192659 |
| 75 | Osteomyelitis (HP:0002754) | 2.39845473 |
| 76 | Colitis (HP:0002583) | 2.39068542 |
| 77 | Abnormality of the pleura (HP:0002103) | 2.36853357 |
| 78 | Slow saccadic eye movements (HP:0000514) | 2.36227824 |
| 79 | Prolonged bleeding time (HP:0003010) | 2.35156851 |
| 80 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.34199892 |
| 81 | Recurrent sinusitis (HP:0011108) | 2.33047450 |
| 82 | Granulocytopenia (HP:0001913) | 2.32817318 |
| 83 | IgA deficiency (HP:0002720) | 2.32587842 |
| 84 | Prostate neoplasm (HP:0100787) | 2.32142397 |
| 85 | Polyneuropathy (HP:0001271) | 2.31849669 |
| 86 | Glomerulopathy (HP:0100820) | 2.31599543 |
| 87 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.30615843 |
| 88 | Abnormality of the pericardium (HP:0001697) | 2.30337960 |
| 89 | Urticaria (HP:0001025) | 2.27140764 |
| 90 | Increased cerebral lipofuscin (HP:0011813) | 2.25189592 |
| 91 | Petechiae (HP:0000967) | 2.15467887 |
| 92 | Arthralgia (HP:0002829) | 2.14250769 |
| 93 | Gingival bleeding (HP:0000225) | 2.13556925 |
| 94 | Hypergammaglobulinemia (HP:0010702) | 2.11550407 |
| 95 | Gastrointestinal stroma tumor (HP:0100723) | 2.11341616 |
| 96 | Abnormality of the endocardium (HP:0004306) | 2.10136638 |
| 97 | Papilledema (HP:0001085) | 2.09387541 |
| 98 | Recurrent pneumonia (HP:0006532) | 2.06680300 |
| 99 | Inflammation of the large intestine (HP:0002037) | 2.06483940 |
| 100 | Bronchitis (HP:0012387) | 2.05063949 |
| 101 | Vertigo (HP:0002321) | 2.04921038 |
| 102 | Abnormality of glycolipid metabolism (HP:0010969) | 2.03080951 |
| 103 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.03080951 |
| 104 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.03080951 |
| 105 | Myocardial infarction (HP:0001658) | 2.02839742 |
| 106 | Increased density of long bones (HP:0006392) | 2.02830510 |
| 107 | Keratitis (HP:0000491) | 2.01525769 |
| 108 | Ureteral stenosis (HP:0000071) | 1.99307384 |
| 109 | Cheilitis (HP:0100825) | 1.99179458 |
| 110 | Restrictive lung disease (HP:0002091) | 1.97160002 |
| 111 | Dysostosis multiplex (HP:0000943) | 1.96315510 |
| 112 | Gastrointestinal inflammation (HP:0004386) | 1.96295243 |
| 113 | Loss of speech (HP:0002371) | 1.95938250 |
| 114 | Hypochromic anemia (HP:0001931) | 1.92535731 |
| 115 | Alveolar cell carcinoma (HP:0006519) | 1.91263294 |
| 116 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.89402725 |
| 117 | Episodic fever (HP:0001954) | 1.88301649 |
| 118 | Premature loss of primary teeth (HP:0006323) | 1.86946131 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.88229394 |
| 2 | MAP4K1 | 4.21848997 |
| 3 | MAP3K14 | 4.09610671 |
| 4 | ITK | 3.02816737 |
| 5 | IKBKE | 2.91060572 |
| 6 | TBK1 | 2.66503248 |
| 7 | NLK | 2.65687301 |
| 8 | JAK3 | 2.62984855 |
| 9 | TYK2 | 2.41666634 |
| 10 | MST4 | 2.38665784 |
| 11 | ZAP70 | 2.31498392 |
| 12 | GRK6 | 2.16593035 |
| 13 | BLK | 2.14277199 |
| 14 | PRPF4B | 2.08615759 |
| 15 | RIPK4 | 2.03995616 |
| 16 | IRAK4 | 2.00033706 |
| 17 | IKBKB | 1.98360183 |
| 18 | IRAK3 | 1.92923702 |
| 19 | * JAK1 | 1.90398123 |
| 20 | MAP3K13 | 1.86428906 |
| 21 | STK10 | 1.86401362 |
| 22 | TEC | 1.81508116 |
| 23 | CSK | 1.78936448 |
| 24 | SYK | 1.70186975 |
| 25 | CAMKK2 | 1.68720984 |
| 26 | LCK | 1.65779358 |
| 27 | CHUK | 1.64486758 |
| 28 | MAP3K10 | 1.58208305 |
| 29 | FGFR4 | 1.52822615 |
| 30 | HCK | 1.52421947 |
| 31 | BTK | 1.50512176 |
| 32 | FGFR3 | 1.43066248 |
| 33 | TAOK3 | 1.42348478 |
| 34 | PIM1 | 1.29289083 |
| 35 | GRK7 | 1.29172390 |
| 36 | STK4 | 1.24401264 |
| 37 | KIT | 1.24286938 |
| 38 | NME2 | 1.16166596 |
| 39 | JAK2 | 1.08859122 |
| 40 | PRKCQ | 1.08124722 |
| 41 | MATK | 1.03359449 |
| 42 | LYN | 1.02953337 |
| 43 | CAMKK1 | 1.02772476 |
| 44 | MARK3 | 0.94277579 |
| 45 | MAP3K3 | 0.93457046 |
| 46 | SIK2 | 0.89423198 |
| 47 | CLK1 | 0.88165613 |
| 48 | MAP2K2 | 0.86702601 |
| 49 | TESK2 | 0.86330340 |
| 50 | RPS6KA4 | 0.83705664 |
| 51 | TYRO3 | 0.83339551 |
| 52 | ERN1 | 0.83158245 |
| 53 | NEK9 | 0.82705920 |
| 54 | TGFBR2 | 0.79624823 |
| 55 | PBK | 0.78822697 |
| 56 | MAP3K11 | 0.78719352 |
| 57 | CDC42BPA | 0.74387683 |
| 58 | MAP3K1 | 0.73995605 |
| 59 | KSR2 | 0.72736590 |
| 60 | TAOK1 | 0.72170513 |
| 61 | CDK12 | 0.69068090 |
| 62 | TAOK2 | 0.67238144 |
| 63 | PASK | 0.64701806 |
| 64 | TRPM7 | 0.62907817 |
| 65 | LRRK2 | 0.60674505 |
| 66 | CSF1R | 0.59033010 |
| 67 | EPHB1 | 0.59007835 |
| 68 | STK24 | 0.55984598 |
| 69 | SIK3 | 0.55905029 |
| 70 | FES | 0.55876051 |
| 71 | MELK | 0.55074441 |
| 72 | PRKCH | 0.54727944 |
| 73 | IRAK1 | 0.54504373 |
| 74 | MARK2 | 0.53474417 |
| 75 | NEK6 | 0.53138460 |
| 76 | PIK3CG | 0.52693460 |
| 77 | CDK6 | 0.52384534 |
| 78 | TLK1 | 0.51185540 |
| 79 | STK38 | 0.49791928 |
| 80 | RAF1 | 0.49471806 |
| 81 | BMX | 0.49227154 |
| 82 | IRAK2 | 0.48544530 |
| 83 | PDGFRB | 0.48483435 |
| 84 | ACVR1B | 0.47403807 |
| 85 | ABL1 | 0.46823266 |
| 86 | PRKCD | 0.45874078 |
| 87 | KDR | 0.45743706 |
| 88 | MAP3K7 | 0.45132531 |
| 89 | CDK4 | 0.44689284 |
| 90 | PKN2 | 0.43221270 |
| 91 | SGK3 | 0.42699131 |
| 92 | NUAK1 | 0.41845714 |
| 93 | SGK2 | 0.40365984 |
| 94 | FYN | 0.39691550 |
| 95 | MAPKAPK2 | 0.38028585 |
| 96 | EPHA3 | 0.37733016 |
| 97 | HIPK2 | 0.37501328 |
| 98 | PDK1 | 0.37323860 |
| 99 | IGF1R | 0.36208801 |
| 100 | MOS | 0.36031016 |
| 101 | MAPK7 | 0.35532375 |
| 102 | CDK9 | 0.35481288 |
| 103 | MAP2K6 | 0.33906995 |
| 104 | INSR | 0.32801828 |
| 105 | RPS6KC1 | 0.32175233 |
| 106 | RPS6KL1 | 0.32175233 |
| 107 | YES1 | 0.31733019 |
| 108 | PIM2 | 0.31345642 |
| 109 | TNK2 | 0.31096108 |
| 110 | BRD4 | 0.31045809 |
| 111 | PTK6 | 0.30511402 |
| 112 | KSR1 | 0.28557183 |
| 113 | TTN | 0.26187583 |
| 114 | EIF2AK2 | 0.25805642 |
| 115 | TRIB3 | 0.25647825 |
| 116 | MAP2K3 | 0.23860992 |
| 117 | DMPK | 0.22584135 |
| 118 | EGFR | 0.21867466 |
| 119 | MAPK3 | 0.21019553 |
| 120 | EEF2K | 0.20610621 |
| 121 | VRK1 | 0.19949704 |
| 122 | MAPK12 | 0.18552868 |
| 123 | RPS6KA6 | 0.18157533 |
| 124 | BMPR2 | 0.17562545 |
| 125 | MAPK4 | 0.17312082 |
| 126 | SRC | 0.16897733 |
| 127 | FLT3 | 0.16677629 |
| 128 | MAPK11 | 0.15601741 |
| 129 | ADRBK2 | 0.15368155 |
| 130 | MAP3K5 | 0.14878724 |
| 131 | FGR | 0.12468672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Primary immunodeficiency_Homo sapiens_hsa05340 | 3.95361739 |
| 2 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.24340169 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.05533355 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.99079873 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.96030652 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.94549402 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.90116503 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.78909678 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.71934388 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.63904512 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.59726071 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.19835615 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.17335018 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.10355776 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.94023204 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.93336278 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.90940978 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.84691095 |
| 19 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.80115384 |
| 20 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.72568963 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.69380723 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.68315837 |
| 23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.63297834 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.60376672 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.59811958 |
| 26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.57761108 |
| 27 | Legionellosis_Homo sapiens_hsa05134 | 1.54569183 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.53665911 |
| 29 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.50595777 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.50171971 |
| 31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.48965035 |
| 32 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.48946528 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.48903849 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.44396095 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.42941097 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.37744893 |
| 37 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.24249291 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.22766949 |
| 39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.22627890 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 1.22316287 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 1.20005821 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.13232604 |
| 43 | Shigellosis_Homo sapiens_hsa05131 | 1.08595978 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.06903708 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 1.00885184 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 0.95655965 |
| 47 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.90363650 |
| 48 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.87331807 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86292859 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.86018051 |
| 51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85277022 |
| 52 | Platelet activation_Homo sapiens_hsa04611 | 0.84338476 |
| 53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.80583522 |
| 54 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77243614 |
| 55 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.73197593 |
| 56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.73184276 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 0.67196461 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65892953 |
| 59 | Other glycan degradation_Homo sapiens_hsa00511 | 0.64156313 |
| 60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63399219 |
| 61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62001348 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60299808 |
| 63 | Colorectal cancer_Homo sapiens_hsa05210 | 0.59582457 |
| 64 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58294035 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57550865 |
| 66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56220366 |
| 67 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55882571 |
| 68 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55661720 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53312666 |
| 70 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50898491 |
| 71 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49019900 |
| 72 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47506599 |
| 73 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.46498125 |
| 74 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.46434270 |
| 75 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44932455 |
| 76 | Endocytosis_Homo sapiens_hsa04144 | 0.42845860 |
| 77 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41050729 |
| 78 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.40814105 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40611200 |
| 80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39959004 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39087475 |
| 82 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.37328498 |
| 83 | Amoebiasis_Homo sapiens_hsa05146 | 0.37326849 |
| 84 | Prostate cancer_Homo sapiens_hsa05215 | 0.36408933 |
| 85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.30739844 |
| 86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.29632185 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.29315149 |
| 88 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.29185640 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28911153 |
| 90 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.28871984 |
| 91 | Thyroid cancer_Homo sapiens_hsa05216 | 0.28792524 |
| 92 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.27523190 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27308740 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.27259467 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.27084536 |
| 96 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.26541645 |
| 97 | Endometrial cancer_Homo sapiens_hsa05213 | 0.26207271 |
| 98 | Circadian rhythm_Homo sapiens_hsa04710 | 0.25317669 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.24970559 |
| 100 | Adherens junction_Homo sapiens_hsa04520 | 0.23991401 |
| 101 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.23685773 |
| 102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.22556990 |
| 103 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.21886490 |
| 104 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.19321510 |
| 105 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.17932755 |
| 106 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.17580214 |
| 107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.17331601 |
| 108 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.16635027 |
| 109 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.16475267 |
| 110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.16004514 |
| 111 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.12554436 |
| 112 | Pathways in cancer_Homo sapiens_hsa05200 | 0.11984963 |

